A federal court in Colorado has sided with a Catholic health care clinic in its challenge to a recent state law that forbids doctors and nurses from administering a natural hormone to reverse the effects of the first step of a medically induced abortion, which the state had implemented in part because of safety concerns.
U.S. Food and Drug Administration
As FDA Considers Artificial Wombs, Ethicist Recommends ‘Courage and Caution’
Catholics should approach the issue of artificial wombs with both courage and caution, an ethicist stressed after U.S. Food and Drug Administration advisers met about the new technology.
Abortions Rise in Most U.S. States Where the Procedure Remains Legal, Data Shows
Legal abortions most likely increased in the United States in the first six months of 2023 compared with 2020, according to a New York Times analysis of data from the Guttmacher Institute, which opposes abortion restrictions.
Texas Lawsuit Demands Planned Parenthood Pay Back Millions in Medicaid Funding
A Texas lawsuit is seeking for Planned Parenthood to pay back millions of funds it received through Medicaid, which the abortion provider says could shutter its operations in the state.
Appeals Court Hears Abortion Pill Case, Next Stop Supreme Court
A federal appeals court in Louisiana is hearing arguments May 17 about the accessibility of the abortion drug mifepristone.
Cameroon Boarding School Graduates Fly to Ireland to Thank Religious Sisters Who Educated Them
Twenty-two women who attended a Catholic boarding school in Cameroon run by Irish missionaries flew to Ireland at the end of April to express their thanks in person to their former teachers, whom they refer to as their “mothers.”
Supreme Court Temporarily Blocks Lower Court Rulings Restricting Abortion Pills Amid Legal Challenge
The U.S. Supreme Court said April 14 it would temporarily keep in place status quo federal regulations regarding the use of an abortion drug, giving the court additional time to consider a lower court’s ruling to stay the U.S. Food and Drug Administration’s approval of the drug.